ABT vs FIP · P/E 25, rev $44.33B vs rev $502.5M
Abbott Laboratories (ABT) versus FTAI Infrastructure Inc. (FIP) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
FTAI Infrastructure Inc. (FIP) is a conglomerates company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported FIP revenue for 2025-12-31 was $502.5M. Net income was -$152.1M. Revenue was up 51.6% from 2024-12-31 to 2025-12-31. FIP currently screens at market cap $560.1M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. FIP currently screens at market cap $560.1M.
Not investment advice. Open the ABT and FIP stock pages for the full models.
Not investment advice.